| Mathematical modeling of biomarker dynamics in cancer patients |
Frederick Adler |
University of Utah |
PLCO |
Nov 14, 2022 |
PLCO-1099 |
| Risk Factors of Prostate Cancer - A Statistical Analysis |
Francesco Patrucco |
Humanitas University |
PLCO |
Nov 9, 2022 |
PLCO-1098 |
| Machine Learning Model to Predict Colorectal Cancer |
Bence Lukacsy |
Barrington High School |
PLCO |
Nov 9, 2022 |
PLCO-1097 |
| Clarifying Lung Cancer Risk Among Breast Cancer Survivors |
Keith Sigel |
The Mount Sinai Hospital |
PLCO |
Nov 9, 2022 |
PLCO-1092 |
| Effect of risk-stratified screening with flexible sigmoidoscopy on colorectal cancer incidence and mortality |
Yubei Huang |
Tianjin Medical University Cancer Institute and Hospital |
PLCO |
Nov 4, 2022 |
PLCO-1094 |
| Reexamine trial outcomes in PLCO to identify interactions of screening effects with screen results and other covariates |
Hormuzd Katki |
NCI |
PLCO |
Nov 1, 2022 |
PLCO-1091 |
| Progression and regression in chest X-ray with lung cancer incidence and mortality in Two Screening Trials |
Ya Liu |
Tianjin Medical University Cancer Institute and Hospital |
PLCO |
Nov 1, 2022 |
PLCO-1090 |
| Association between use of non-steroidal anti-inflammatory drugs (NSAIDs) and risk of pancreatic cancer in a national prospective cohort study |
Yunpeng Yu |
Indiana University |
PLCO |
Nov 1, 2022 |
PLCO-1088 |
| Colorectal cancer predicting model established on a large prospective screening project. |
Ziqi Zhang |
Sun Yat-Sen University Cancer Center |
PLCO |
Nov 1, 2022 |
PLCO-1087 |
| ANALYSIS OF THE EFFECT OF CHEMOTHERAPY IN OVARIAN CANCER TREATMENT USING DATA MINING |
Kezban Alpan |
Middlesex University |
PLCO |
Nov 1, 2022 |
PLCO-1089 |
| Diabetes risk reduction diet and colorectal carcinogenesis: a prospective cohort study |
Chengcheng Liu |
The Second Affiliated Hospital, Zhejiang University School of Medicine |
PLCO |
Oct 27, 2022 |
PLCO-1082 |
| Integrating genetic susceptibility, blood biomarkers, and traditional factors to develop risk-adapted colonoscopy surveillance strategies |
Chengcheng Liu |
The Second Affiliated Hospital, Zhejiang University School of Medicine |
PLCO |
Oct 27, 2022 |
PLCO-1083 |
| Assessing the effect of different kinds of explanations on how much people trust a cancer diagnosis |
Ben Armstrong |
Massachusetts Institute of Technology |
PLCO |
Oct 27, 2022 |
PLCO-1080 |
| Alcohol Intake Across the Life Course and Risk of Ovarian Cancer in Postmenopausal Women |
Alexandra Schmidt |
University of North Dakota |
PLCO |
Oct 19, 2022 |
PLCO-1078 |
| Utilization of machine learning to create a predictive model for ovarian cancer based on pelvic ultrasound, CA-125, and clinical characteristics |
Graham Chapman |
Case Western Reserve University |
PLCO |
Oct 18, 2022 |
PLCO-1074 |
| Global metabolomics profiling, dietary factors, and colorectal cancer risk in the NIHConsortium of Metabolomics Studies (COMETS) |
Mary Playdon |
University of Utah |
PLCO |
Oct 18, 2022 |
PLCO-1067 |
| Impact of Data Driven Decision Making in Healthcare Analytic |
May Myat |
University of Technology, Yatanarpon Cyber City(UTYCC), Pyin Oo Lwin, Myanmar |
PLCO |
Oct 18, 2022 |
PLCO-1064 |
| Mathematical modelling of prostate cancer data |
Taylor deVet |
McMaster University |
PLCO |
Oct 18, 2022 |
PLCO-1073 |
| Risk-stratified multi-round PSA screening for prostate cancer incorporating population-based screening reference level and subgroup-specific progression indicators |
Huang Yubei |
Tianjin Medical University Cancer Institute and Hospital |
PLCO |
Oct 11, 2022 |
PLCO-1072 |
| Causal inference with incomplete compliance or outcomes truncated by death |
Aixian Chen |
School of Economics and Statistics, Guangzhou University, Guangzhou, China |
PLCO |
Oct 11, 2022 |
PLCO-1069 |
